Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Leptomeningeal amyloidosis: features of the clinical picture (clinical observation)

https://doi.org/10.14412/2074-2711-2022-6-67-72

Abstract

Hereditary transthyretin amyloidosis belongs to a group of diseases with an autosomal dominant type of transmission and a heterogeneous clinical picture, which depends on the type of transthyretin gene mutation. The leptomeningeal form is a rare phenotypic variant of amyloidosis with a predominant involvement of brain and spinal cord meninges, as well as cortical meningeal vessels. The main manifestations of this phenotype include cephalalgic syndrome, episodes of acute cerebrovascular accident, hearing impairment, epileptic seizures, progressive cognitive impairment reaching the degree of dementia, impaired consciousness, etc. The article describes a clinical case of revealing of amyloidogenic mutation Ala45Thr with a hereditary family history and typical manifestations of leptomeningeal amyloidosis at the onset of the disease, as well as impaired renal function. Neuroimaging with contrast enhancement revealed a characteristic thickening of the meninges of the spinal cord due to the deposition of amyloid masses.

About the Authors

E. I. Safiulina
Kozhevnikov Clinic of Nervous Diseases
Russian Federation

Elvira Irekovna Safiulina

119021, Moscow, Rossolimo St., 11, Build. 1


Competing Interests:

There are no conflicts of interest.



O. E. Zinovieva
Department of Nervous System Diseases and Neurosurgery, N.V. Sklifosovsky Institute of Clinical Medicine
Russian Federation

119021, Moscow, Rossolimo St., 11, Build. 1


Competing Interests:

There are no conflicts of interest.



N. S. Shcheglova
Kozhevnikov Clinic of Nervous Diseases
Russian Federation

119021, Moscow, Rossolimo St., 11, Build. 1


Competing Interests:

There are no conflicts of interest.



V. V. Rameev
Department of Internal Diseases, Professional Diseases and Rheumatology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation

119021, Moscow, Rossolimo St., 11, Build. 4


Competing Interests:

There are no conflicts of interest.



Z. V. Surnina
M.M. Krasnov Research Institute of Eye Diseases
Russian Federation

119021, Moscow, Rossolimo St., 11A, B


Competing Interests:

There are no conflicts of interest.



E. N. Nikitina
Regional Consultative and Diagnostic Center
Russian Federation

344000, Rostov-on-Don, Pushkin St., 127


Competing Interests:

There are no conflicts of interest.



O. A. Vorobieva
National Center for Clinical Morphological Diagnostics
Russian Federation

192071, St. Petersburg, Slavy Prosp., 32


Competing Interests:

There are no conflicts of interest.



References

1. Safiullina EI, Zinovieva OE, Rameev VV, et al. Damage to the peripheral nervous system in systemic amyloidosis. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):12-8 (In Russ.).

2. Schmidt H, Cruz MW, Botteman MF, et al. Global epidemiology of transthyretin hereditary amyloid polyneuropathy: a systematic review. Amyloid. 2017 Mar;24(sup1):111-2. doi:10.1080/13506129.2017.1292903

3. Sekijima Y. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry. 2015 Sep;86(9):1036-43. doi:10.1136/jnnp-2014-308724. Epub 2015 Jan 20.

4. Rameev VV. Modern methods of diagnosis and treatment of transthyretin hereditary amyloidosis. Manage pain. 2018;(1):20-4 (In Russ.).

5. Rameev VV. Sistemnyy amiloidoz na sovremennom etape: rol' porazheniya pochek v progressirovanii zabolevaniya, puti optimizatsii diagnostiki i uluchsheniya prognoza: Dis. … dokt. med. nauk [Systemic amyloidosis at the present stage: the role of kidney damage in the progression of the disease, ways to optimize diagnosis and improve prognosis: Dissertation of the Doctor of Medical Sciences]. Moscow; 2020. 228 p. (In Russ.).

6. Yarlas A, Gertz MA, Dasgupta NR, et al. Burden of hereditary transthyretin amyloidosis on quality of life. Muscle Nerve. 2019 Aug;60(2):169-75. doi:10.1002/mus.26515. Epub 2019 Jun 13.

7. Qin Q, Wei C, Piao Y, et al. Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations. Neurologist. 2021 Sep 7;26(5):189-95. doi:10.1097/NRL.0000000000000337

8. Rameev VV, Kozlovskaya LV. Amyloidosis: modern methods of diagnosis and treatment. Effektivnaya farmakoterapiya = Effective Pharmacotherapy. 2012;44:6-15 (In Russ.).

9. Adyan TA, Polyakov AV. Hereditary transthyretin amyloidosis. Nervno-myshechnyye bolezni = Neuromuscular Diseases. 2019;9(4):12-25 (In Russ.).

10. Goren H, Steinberg MC, Farboody GH. Familial oculoleptomeningeal amyloidosis. Brain. 1980 Sep;103(3):473-95. doi:10.1093/brain/103.3.473

11. Nakamura M, Yamashita T, Ueda M, et al. Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis. Neurology. 2005 Oct 11;65(7):1051-6. doi:10.1212/01.wnl.0000178983.20975.af

12. Uitti RJ, Donat JR, Rozdilsky B, et al. Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. Arch Neurol. 1988 Oct;45(10):1118-22. doi:10.1001/archneur.1988.00520340072015

13. Roe RH, Fisher Y, Eagle RC Jr, et al. Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. Ophthalmology. 2007 Nov;114(11):e33-7. doi:10.1016/j.ophtha.2007.07.007

14. Mathieu F, Morgan E, So J, et al. Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation. World Neurosurg. 2018 Mar;111:190-3. doi:10.1016/j.wneu.2017.12.096. Epub 2017 Dec 23.

15. Nikitina EN, Vorobyeva OA. Familial transthyretin amyloidosis: a mini-review and description of three cases among members of the same family. Nefrologiya i dializ = Nephrology and Dialysis. 2018;20(3):312-23 (In Russ.).

16. Uemichi T, Uitti RJ, Koeppen AH, et al. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol. 1999 Sep;56(9):1152-5. doi:10.1001/archneur.56.9.1152

17. Garzuly F, Vidal R, Wisniewski T, et al. Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology. 1996 Dec;47(6):1562-7. doi:10.1212/wnl.47.6.1562. Erratum in: Neurology. 1997 Apr;48(4):1143.

18. Beckius S, Shah K. Intracranial and systemic manifestations of familial leptomeningeal amyloidosis, as seen on CT and MRI. Radiol Case Rep. 2018 Sep 13;13(6):1179-84. doi:10.1016/j.radcr.2018.07.030

19. Kleefeld F, Knebel F, Eurich D, et al. Familial Oculo-Leptomeningeal Transthyretin Amyloidosis Caused by Leu55Arg Mutation. J Neuromuscul Dis. 2020;7(4):515-9. doi:10.3233/JND-200542


Review

For citations:


Safiulina EI, Zinovieva OE, Shcheglova NS, Rameev VV, Surnina ZV, Nikitina EN, Vorobieva OA. Leptomeningeal amyloidosis: features of the clinical picture (clinical observation). Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(6):67-72. (In Russ.) https://doi.org/10.14412/2074-2711-2022-6-67-72

Views: 424


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)